Table 2 Test(s) of choice in asymptomatic women.
| Site or specimen | Gonorrhoea | Chlamydia | Syphilis | HIV |
|---|---|---|---|---|
| Urethra | NR | NR | NR | NR |
| Cervix | Culture | NAAT | NR | NR |
| Vagina | NR | NR | NR | |
| Self taken tampons or swabs | NAAT | |||
| Vulval‐introital | NAAT | |||
| Posterior fornix | NAAT | |||
| Rectum | NR | NR | NR | NR |
| Oropharynx | NR | NR | NR | NR |
| Urine | NR | NAAT* | NR | NR |
| Blood | NR | NR | EIA or TPPA or cardiolipin test plus TPHA | EIA |
*If urethral specimen not available.
NR, not recommended; NAAT, nucleic acid amplification test; EIA, enzyme immunoassay; TPPA, Treponema pallidum particle assay; TPHA, Treponema pallidum haemagglutination assay.